Agilent Technologies, Inc. (A) Guidance & Earnings Results

On 2026-08-26 Agilent Technologies, Inc. raised guidance: "FY26 revenue raised to $7.49-7.51B from prior midpoint of $7.44B (implied); FY26 non-GAAP EPS raised to $6.18-6.21 from prior midpoint of $6.04 (implied); Q4 FY26 revenue $1.98-2.0B; Q4 non-GAAP EPS…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

AAgilent Technologies, Inc.Follow A — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 48.8B
P/E TTM: 34.1
Dividend yield: 0.6%
52-week: —
Next earnings: 23 Nov, in 30 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
26 Aug 26	Raised	FY26 revenue raised to $7.49-7.51B from prior midpoint of $7.44B (implied); FY26 non-GAAP EPS raised to $6.18-6.21 from prior midpoint of $6.04 (implied); Q4 FY26 revenue $1.98-2.0B; Q4 non-GAAP EPS $1.71-1.74 · full year
27 May 26	Raised	FY26 revenue midpoint raised 30bps, EPS midpoint +$0.08 · full year
25 Feb 26	Raised	FY26 revenue guidance raised to $7.3B-$7.5B (from prior), non-GAAP EPS raised to $5.90-$6.04 · full year
24 Nov 25	Raised	FY2026 revenue guidance $7.3B-$7.4B (+5-7% reported); Q1 FY2026 revenue $1.79B-$1.82B · full year
27 Aug 25	Raised	FY25 revenue raised to $6.91-$6.93B; non-GAAP EPS raised to $5.56-$5.59 · full year

Agilent Technologies, Inc. — questions

What guidance did Agilent Technologies, Inc. give?: On 2026-08-26: "FY26 revenue raised to $7.49-7.51B from prior midpoint of $7.44B (implied); FY26 non-GAAP EPS raised to $6.18-6.21 from prior midpoint of $6.04 (implied); Q4 FY26 revenue $1.98-2.0B; Q4 non-GAAP EPS $1.71-1.74"
When does Agilent Technologies, Inc. report earnings?: Agilent Technologies, Inc.'s next earnings report is expected on 2026-11-23.

Every figure on this page comes from Agilent Technologies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.